Petros Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-15.3M | $-15.3M | $4.6K | — |
| FY2021 | $-11.9M | $-11.9M | — | $1.3M |
| FY2022 | $-12.8M | $-12.8M | — | $1.2M |
| FY2023 | $-7.6M | $-7.6M | — | $417.2K |
| FY2024 | $-2.6M | $-2.6M | $24.6K | $197.2K |
| FY2025 | $-6.7M | $-6.7M | — | $304.6K |